These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36930101)

  • 61. A Case for Cross-Border Governance? A Comparative Trend Assessment of COVID-19 Transmission, Vaccination, and Outcomes Among 35 Nations in Europe Across 18 months.
    Cuschieri S; Cuschieri A; Farrugia E; Diacono E; Balzan E; Grupetta M; Vella A; Cutajar C; Formosa M; Barbara M; Mintoff F; Shaw C; Fleri-Soler S; Borg N; Pace G; Vella L; Pisani R; Attard-Mallia T; Gouder M; Attard R; Grixti N; Scicluna M; Borda T; Bartolo K; Chircop R; Degabrielle-Ferrante E; Mallia M; Attard M; Frendo N; Gatt G; Damato G; Riolo N; Muscat-Baron L; Galea M; Grech E
    Disaster Med Public Health Prep; 2022 May; 17():e196. PubMed ID: 35492012
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Yellow fever vaccination before and during the covid-19 pandemic in Brazil.
    Silva TMRD; Nogueira de Sá ACMG; Prates EJS; Rodrigues DE; Silva TPRD; Matozinhos FP; Vieira EWR
    Rev Saude Publica; 2022; 56():45. PubMed ID: 35703600
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The use of the time-to-event index (Tevent) to compare the negative impact of COVID-19 on public health among continents/regions in 2020 and 2021: An observational study.
    Chuang HY; Wu HM; Chien TW; Chou W; Chen SH
    Medicine (Baltimore); 2022 Dec; 101(49):e30249. PubMed ID: 36626433
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of prediction accuracies between two mathematical models for the assessment of COVID-19 damage at the early stage and throughout 2020.
    Chuang HY; Chien TW; Chou W; Wang CY; Tsai KT
    Medicine (Baltimore); 2022 Aug; 101(32):e29718. PubMed ID: 35960054
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.
    Chukwu OA; Kapiriri L; Essue B
    Int J Pharm Pract; 2022 Jun; 30(3):284-287. PubMed ID: 35468198
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Financing COVID-19 vaccination in sub-Saharan Africa: lessons from a nation-wide willingness to pay (WTP) survey in Ghana.
    Alhassan RK; Nketiah-Amponsah E; Immurana M; Abuosi AA
    BMC Public Health; 2022 Jun; 22(1):1273. PubMed ID: 35773637
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Features Constituting Actionable COVID-19 Dashboards: Descriptive Assessment and Expert Appraisal of 158 Public Web-Based COVID-19 Dashboards.
    Ivanković D; Barbazza E; Bos V; Brito Fernandes Ó; Jamieson Gilmore K; Jansen T; Kara P; Larrain N; Lu S; Meza-Torres B; Mulyanto J; Poldrugovac M; Rotar A; Wang S; Willmington C; Yang Y; Yelgezekova Z; Allin S; Klazinga N; Kringos D
    J Med Internet Res; 2021 Feb; 23(2):e25682. PubMed ID: 33577467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and Safety of a Protein-Based SARS-CoV-2 Vaccine: A Randomized Clinical Trial.
    Mostafavi E; Eybpoosh S; Karamouzian M; Khalili M; Haji-Maghsoudi S; Salehi-Vaziri M; Khamesipour A; Jalali T; Nakhaeizadeh M; Sharifi H; Mansoori Y; Keramat F; Ghodrati S; Javanian M; Doroud D; Omrani MD; Asadi H; Pouriayevali MH; Ghasemian R; Farshidi H; Pourahmad M; Ghasemzadeh I; Mounesan L; Darvishian M; Mirjalili MR; Toledo-Romani ME; Valenzuela-Silva C; Verez-Bencomo V; Gouya MM; Emadi-Koochak H; Haghdoost AA; Biglari A;
    JAMA Netw Open; 2023 May; 6(5):e2310302. PubMed ID: 37133864
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Using the IPcase Index with Inflection Points and the Corresponding Case Numbers to Identify the Impact Hit by COVID-19 in China: An Observation Study.
    Wang LY; Chien TW; Chou W
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33670825
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of prediction accuracies between mathematical models to make projections of confirmed cases during the COVID-19 pandamic by country/region.
    Tsai KT; Chien TW; Lin JK; Yeh YT; Chou W
    Medicine (Baltimore); 2021 Dec; 100(50):e28134. PubMed ID: 34918666
    [TBL] [Abstract][Full Text] [Related]  

  • 72. How education and GDP drive the COVID-19 vaccination campaign.
    Ngo VM; Zimmermann KF; Nguyen PV; Huynh TLD; Nguyen HH
    Arch Public Health; 2022 Jul; 80(1):171. PubMed ID: 35850775
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Higher COVID-19 Vaccination Rates Are Associated with Lower COVID-19 Mortality: A Global Analysis.
    Hoxha I; Agahi R; Bimbashi A; Aliu M; Raka L; Bajraktari I; Beqiri P; Adams LV
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679919
    [TBL] [Abstract][Full Text] [Related]  

  • 74. U.S. COVID-19 State Government Public Dashboards: An Expert Review.
    Fareed N; Swoboda CM; Chen S; Potter E; Wu DTY; Sieck CJ
    Appl Clin Inform; 2021 Mar; 12(2):208-221. PubMed ID: 33853140
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccination associated with gross domestic product and fewer deaths in countries and regions: A verification study.
    Wang LY; Chien TW; Lin JK; Chou W
    Medicine (Baltimore); 2022 Jan; 101(4):e28619. PubMed ID: 35089198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Are interactive and tailored data visualizations effective in promoting flu vaccination among the elderly? Evidence from a randomized experiment.
    Cotter LM; Yang S
    J Am Med Inform Assoc; 2024 Jan; 31(2):317-328. PubMed ID: 37218375
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Information Disclosure Contents of the COVID-19 Data Dashboard Websites for South Korea, China, and Japan: A Comparative Study.
    Zhao B; Kim M; Nam EW
    Healthcare (Basel); 2021 Nov; 9(11):. PubMed ID: 34828533
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of COVID-19 vaccines on economic activity.
    Deb P; Furceri D; Jimenez D; Kothari S; Ostry JD; Tawk N
    Swiss J Econ Stat; 2022; 158(1):3. PubMed ID: 35036364
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Constructing a Learning Curve to Discuss the Medical Treatments and the Effect of Vaccination of COVID-19.
    Chen YT; Su EC; Hung FM; Hiramatsu T; Hung TJ; Kuo CY
    Healthcare (Basel); 2023 May; 11(11):. PubMed ID: 37297731
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gaps between official and excess Covid-19 mortality measures: The effects of institutional quality and vaccinations.
    Aizenman J; Cukierman A; Jinjarak Y; Nair-Desai S; Xin W
    Econ Model; 2022 Nov; 116():105990. PubMed ID: 36034169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.